In a stark reflection of the challenges facing the market, KLTO stock has tumbled to a 52-week low, with shares dropping to just $0.5. This significant downturn is part of a broader trend for Redwoods ...

In a challenging year for Redwoods Acquisition Corp., the KLTO stock has hit a 52-week low, trading at $0.46. This price point marks a significant downturn for the company, which has seen its value ...

Shares of Klotho Neurosciences, Inc. (NASDAQ:KLTO) have soared more than 1000% over the past three months on promising results and breakthrough hopes. Klotho stock was in the spotlight again Thursday ...

Klotho Neurosciences (KLTO) experienced an extraordinary 800% stock surge on June 9, 2025, following the announcement of promising pre-clinical study results. The company’s research demonstrated that ...

Klotho Neurosciences (KLTO) stock rocketed higher on Monday after the biopharmaceutical company announced a new approach that could extend patient lifespan. The company’s pre-clinical data suggested ...

The stock's market capitalization stands at a modest $10.42 million, reflecting the significant decline mentioned in the article. InvestingPro Tips highlight that KLTO is trading near its 52-week low ...

Elimination of Future Dilution: The Company will no longer be required to issue new common stock to SkyBell, which would have resulted in SkyBell owning 90% of the Company—substantially diluting ...

*Today’s High/Low is only updated during regular trading hours; and does not include trades occurring in pre-market or after-hours. Nasdaq Official Closing Price (NOCP)" is a process for identifying ...

In a challenging year for Redwoods Acquisition, the KLTO stock has plummeted to a 52-week low, trading at $0.28. This significant downturn reflects a staggering 1-year change, with the stock value ...